Are C.Uyemura & Co.,Ltd. (TSE:4966) Investors Paying Above The Intrinsic Value?
Key Insights
- Using the 2 Stage Free Cash Flow to Equity, C.UyemuraLtd fair value estimate is JP¥8,588
- C.UyemuraLtd is estimated to be 27% overvalued based on current share price of JP¥10,900
- C.UyemuraLtd's peers seem to be trading at a lower premium to fair value based onthe industry average of -15%
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of C.Uyemura & Co.,Ltd. (TSE:4966) as an investment opportunity by taking the expected future cash flows and discounting them to their present value. One way to achieve this is by employing the Discounted Cash Flow (DCF) model. It may sound complicated, but actually it is quite simple!
We would caution that there are many ways of valuing a company and, like the DCF, each technique has advantages and disadvantages in certain scenarios. For those who are keen learners of equity analysis, the Simply Wall St analysis model here may be something of interest to you.
See our latest analysis for C.UyemuraLtd
Is C.UyemuraLtd Fairly Valued?
We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows. Generally the first stage is higher growth, and the second stage is a lower growth phase. In the first stage we need to estimate the cash flows to the business over the next ten years. Seeing as no analyst estimates of free cash flow are available to us, we have extrapolate the previous free cash flow (FCF) from the company's last reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.
Generally we assume that a dollar today is more valuable than a dollar in the future, so we discount the value of these future cash flows to their estimated value in today's dollars:
10-year free cash flow (FCF) estimate
2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | |
Levered FCF (¥, Millions) | JP¥8.24b | JP¥7.93b | JP¥7.73b | JP¥7.60b | JP¥7.52b | JP¥7.46b | JP¥7.43b | JP¥7.41b | JP¥7.40b | JP¥7.40b |
Growth Rate Estimate Source | Est @ -5.33% | Est @ -3.67% | Est @ -2.51% | Est @ -1.70% | Est @ -1.13% | Est @ -0.73% | Est @ -0.45% | Est @ -0.26% | Est @ -0.12% | Est @ -0.02% |
Present Value (¥, Millions) Discounted @ 5.5% | JP¥7.8k | JP¥7.1k | JP¥6.6k | JP¥6.1k | JP¥5.7k | JP¥5.4k | JP¥5.1k | JP¥4.8k | JP¥4.6k | JP¥4.3k |
("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = JP¥58b
We now need to calculate the Terminal Value, which accounts for all the future cash flows after this ten year period. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 0.2%. We discount the terminal cash flows to today's value at a cost of equity of 5.5%.
Terminal Value (TV)= FCF2033 × (1 + g) ÷ (r – g) = JP¥7.4b× (1 + 0.2%) ÷ (5.5%– 0.2%) = JP¥139b
Present Value of Terminal Value (PVTV)= TV / (1 + r)10= JP¥139b÷ ( 1 + 5.5%)10= JP¥81b
The total value is the sum of cash flows for the next ten years plus the discounted terminal value, which results in the Total Equity Value, which in this case is JP¥138b. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Compared to the current share price of JP¥11k, the company appears slightly overvalued at the time of writing. Valuations are imprecise instruments though, rather like a telescope - move a few degrees and end up in a different galaxy. Do keep this in mind.
The Assumptions
The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. If you don't agree with these result, have a go at the calculation yourself and play with the assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at C.UyemuraLtd as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 5.5%, which is based on a levered beta of 0.949. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.
SWOT Analysis for C.UyemuraLtd
- Debt is not viewed as a risk.
- Dividends are covered by earnings and cash flows.
- Earnings growth over the past year underperformed the Chemicals industry.
- Dividend is low compared to the top 25% of dividend payers in the Chemicals market.
- Expensive based on P/E ratio and estimated fair value.
- Annual revenue is forecast to grow faster than the Japanese market.
- No apparent threats visible for 4966.
Moving On:
Valuation is only one side of the coin in terms of building your investment thesis, and it ideally won't be the sole piece of analysis you scrutinize for a company. DCF models are not the be-all and end-all of investment valuation. Rather it should be seen as a guide to "what assumptions need to be true for this stock to be under/overvalued?" For example, changes in the company's cost of equity or the risk free rate can significantly impact the valuation. What is the reason for the share price exceeding the intrinsic value? For C.UyemuraLtd, we've compiled three essential aspects you should explore:
- Financial Health: Does 4966 have a healthy balance sheet? Take a look at our free balance sheet analysis with six simple checks on key factors like leverage and risk.
- Future Earnings: How does 4966's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.
- Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!
PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the TSE every day. If you want to find the calculation for other stocks just search here.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About TSE:4966
C.UyemuraLtd
Researches, develops, manufactures, and sells plating chemicals, industrial chemicals, non-ferrous metals, and other products in Japan and internationally.
Flawless balance sheet with solid track record and pays a dividend.